TP53 and breast carcinoma: To further verify that the tumor suppressor function of piR-36,712 is finally mediated by P53, we used PFT-α, a P53 pharmacological inhibitor, to explore whether it has any effects on the malignant phenotypes of breast cancer cells caused by piR-36,712.